17
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Clinically-Occult Mixed Cellularity Hodgkin's Disease with Charcot-Leyden Crystals

&
Pages 153-157 | Received 24 Dec 1995, Published online: 01 Jul 2009

References

  • Leyden E. Zur Kenntnis des Bronchialasthma. Arch. Pathol. Anal. 1872; 54: 324–352
  • Sakula A. Charcot-Leyden crystals and Curschmann's spirals in asthmatic sputum. Thorax 1986; 41: 503–507
  • Junod C. Isospora belli coccidiosis in immunocompetent subjects (a study of 40 cases seen in Paris). Bull, de la Soc. de Pathol. Exot. et de Ses. Filial. 1988; 81: 317–325
  • Naylor B., Novak D. M. Charcot-Leyden crystals inpleural fluids. Acta Cytol 1985; 29: 781–784
  • Del Blanco J., Valverde J., Mateo L., Juanola X., Pons M., Ferrer J. Charcot-Leyden crystals in synovial fluid. J. Rheum. 1991; 18: 1944
  • Charcot J. M., Robin C. Observations de leucocythemie. C. R. Mem. Soc. Biol. (Paris) 1853; 5: 44–50
  • Kanner R. E., Hammar S. P. Chronic eosinophilic pneumonia: Ultrastructural evidence of marked immunoglobulin production plus macrophagic ingestion of eosinophils and eosinophilic lysosomes leading to intracytoplasmic Charcot-Leyden crystals. Chest 1977; 71: 95–98
  • Schnitzler L., Verret J. L., Schubert B. Granuloma faciale: Ultrastructural study of three cases. J. Cutan. Pathol. 1977; 4: 123–133
  • Chalifoux L. V., King N. W. Eosinophilic myelocytomain an owl monkey (Aotus trivirgatus). Lab. Anim. Sci. 1983; 33: 189–191
  • Kuto F., Nagaoka T., Watanabe Y., et al. Chronic myelocytic leukemia: ultrastructural histopathology of bone marrow from patients in the chronic phase. Ultrastruct. Pathol. 1984; 6: 307–317
  • Kanitakis J., Schmitt D., Euvrard S., Thivolet J. Ultrastructural observation of Charcot-Leyden crystals in mechlorethamine-treated cutaneous lesions of histiocytosis X. J. Am. Acad. Dermatol. 1986; 3: 483–486
  • Carson H. J., Buschmann R. J., Weisz-Carrington P., Choi Y. S. Identification of Charcot-Leyden crystals by electron microscopy. Ultrastruct. Pathol. 1992; 16: 403–411
  • Dvorak A. M., Letourneau L., Weller P. F., Ackerman S. J. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) to intracytoplasmic crystals in tumor cells of primary solid and papillary epithelial neoplasm of the pancreas. Lab. Invest. 1990; 62: 590–607
  • Weller P. F., Goetzl E. J., Austen K. F. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals. Proc. Natl. Acad. Sci. USA 1980; 77: 7440–7443
  • Gleich G. J., Loegering D. A., Mann K. G., Maldonado J. E. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J. Clin. Invest. 1976; 57: 633–40
  • Ackerman S. J., Durack D. T., Gleich G. J. Eosinophil effector mechanisms in health and disease. Advances in Host Defense Mechanisms, J. I. Gallin, A. S. Fauci. Raven, New York 1982; 265–293
  • Jong E. C., Klebanoff S. J. Eosinophil-mediated mammalian tumor cell cytotoxicity: role of the peroxidase system. J. Immunol. 1980; 124: 1949–1953
  • Reinbach G. Uber des Verhalten der Leukozyten bei malignen Tumoren. Arch. Klin. Chir. 1893; 46: 486–562
  • Isaacson N. H., Rapoport P. Eosinophilia in malignant tumors: Its significance. Ann. Intern. Med. 1946; 25: 893–902
  • Bostrom S. G., Hart W. R. Carcinoma of the cervix with intense stromal eosinophilia. Cancer 1981; 47: 2887–2893
  • Butterfield J. H., Dephart G. M., Banks P. M., Gleich G. J. Extracellular deposition of eosinophil granule major basic protein in lymph nodes of patients with Hodgkin's disease. Blood 1986; 68: 1250–1256
  • Ghadially F. N., Murphy F., Lalond J.-M. A. Eosinophil-mediated necrosis in a malignant fibrous histiocytoma. Ann. Pathol.(Paris) 1982; 2: 57–9
  • Lukes R. J., Craver L. F., Hall T. C., Rappaport H., Ruben P. Report of the Nomenclature Committee. Cancer Res. 1966; 26: 1311
  • Anastasi J., Bitter M. A., Vardiman J. W. The histopathologic diagnosis and subclassification of Hodgkin's disease. Hem. Oncol. Clin. North Am. 1989; 3: 187–204
  • Hodgkin's disease. American Joint Committee on Cancer Manual for Staging of CancerFourth Edition, O. H. Beahrs, D. E. Henson, R. V. P. Hutter, B. J. Kennedy. J. B. Lippincott, Philadelphia 1992; 253–255
  • Ben-Ezra J., Sheibani K., Swartz W., Stroup R., Traveele S. T., Kezirian J., Rappaport H. Relationship between eosinophil density and T-cell activation markers in lymph nodes of patients with Hodgkin's disease. Hum. Pathol. 1989; 20: 1181–5
  • Samoszuk M., Sholly S., Epstien A. L. Eosinophil peroxidase is detectable with a monoclonal antibody in collagen bands of nodular sclerosis Hodgkin's disease. Lab. Invest. 1987; 56: 394–400
  • Samoszuk M. K., Nathwani B. N., Lukes R. J. Extensive deposition of eosinophil peroxidase in Hodgkin's and non-Hodgkin's lymphomas. Am. J. Pathol. 1986; 125: 426–429
  • Kadin M., Butmarc J., Elovic A., Wong D. Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease. Am. J. Pathol. 1993; 142: 11–16
  • Strum S. B., Rappaport H. The persistence of Hodgkin's disease in long-term survivors. Am. J. Med. 1971; 51: 222–40

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.